6533b7cffe1ef96bd1257fc5

RESEARCH PRODUCT

PVSG and WHO bone marrow evaluation in 90 essential thrombocythaemia (ET) patients treated with Peg interferon A2b. Preliminary results

Gugliotta LBulgarelli STieghi AAsioli AGardini GSabattini EVito Franco

subject

http://hdl.handle.net/10447/29301